Dissecting investor and market access trends and drivers for I-O R&D insights

IMMUNO-ONCOLOGY INSIGHTS

Dissecting investor and market access trends and drivers for I-O R&D insights

February 2022
Dissecting investor and market access trends and drivers for I-O R&D insights
Download PDF

Commentary

Raiders of the lost art: finding immuno-oncology treasure

Raiders of the lost art: finding immuno-oncology treasure

Kishore K Gangangari, Anthony Murphy, Reni Benjamin
21 March 2022
Read
Immuno-oncology therapies: a looming mid-life crisis?

Immuno-oncology therapies: a looming mid-life crisis?

Hansoo Kim, Danny Liew, Stephen Goodall
15 March 2022
Read

Viewpoint

Early-stage investment in immuno oncology: riding the waves of hope & hype

Early-stage investment in immuno oncology: riding the waves of hope & hype

W Joost Lesterhuis, H Mikkelsen, J Tobin et al.
15 March 2022
Read